Oxford Pharmascience Ltd.
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Private
- Established
- 2008-01-01
- Employees
- 1
- Market Cap
- -
Impact of Excipients on Pharmacokinetics of OXPzero(TM) Ibuprofen
Phase 1
Completed
- Conditions
- Pharmacokinetics
- Interventions
- First Posted Date
- 2016-11-28
- Last Posted Date
- 2017-05-03
- Lead Sponsor
- Oxford Pharmascience Ltd
- Target Recruit Count
- 30
- Registration Number
- NCT02974361
- Locations
- 🇬🇧
Simbec Orion Ltd, Merthyr Tydfil, United Kingdom
Pilot Study of OXP001(2) and Brufen in Healthy Subjects
- First Posted Date
- 2015-08-13
- Last Posted Date
- 2015-10-28
- Lead Sponsor
- Oxford Pharmascience Ltd
- Target Recruit Count
- 53
- Registration Number
- NCT02521207
- Locations
- 🇬🇧
Quotient Clinical Ltd, Nottingham, Notts, United Kingdom
Pilot Study of OXP005 to Assess Gastroduodenal Irritation
- First Posted Date
- 2015-04-06
- Last Posted Date
- 2015-06-18
- Lead Sponsor
- Oxford Pharmascience Ltd
- Registration Number
- NCT02408978
- Locations
- 🇬🇧
Quotient Clinical Ltd, Nottingham, United Kingdom
Phase I Study PK Study With OXP005 and Naprosyn
- First Posted Date
- 2015-01-30
- Last Posted Date
- 2015-04-01
- Lead Sponsor
- Oxford Pharmascience Ltd
- Registration Number
- NCT02351024
- Locations
- 🇬🇧
Quotient Clinical Ltd, Nottingham, United Kingdom
Pilot Study of OXP001 and Brufen in Healthy Subjects
- First Posted Date
- 2014-01-31
- Last Posted Date
- 2014-04-30
- Lead Sponsor
- Oxford Pharmascience Ltd
- Target Recruit Count
- 43
- Registration Number
- NCT02050958
- Locations
- 🇬🇧
Quotient Clinical, Nottingham, United Kingdom
© Copyright 2025. All Rights Reserved by MedPath